INSM
Price
$99.49
Change
-$2.25 (-2.21%)
Updated
Jun 27 closing price
Capitalization
18.9B
31 days until earnings call
MDWD
Price
$19.26
Change
-$0.13 (-0.67%)
Updated
Jun 27 closing price
Capitalization
208.26M
44 days until earnings call
Interact to see
Advertisement

INSM vs MDWD

Header iconINSM vs MDWD Comparison
Open Charts INSM vs MDWDBanner chart's image
Insmed
Price$99.49
Change-$2.25 (-2.21%)
Volume$34.49M
Capitalization18.9B
MediWound
Price$19.26
Change-$0.13 (-0.67%)
Volume$174.72K
Capitalization208.26M
INSM vs MDWD Comparison Chart in %
Loading...
INSM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MDWD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
INSM vs. MDWD commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INSM is a StrongBuy and MDWD is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (INSM: $99.49 vs. MDWD: $19.26)
Brand notoriety: INSM and MDWD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: INSM: 844% vs. MDWD: 272%
Market capitalization -- INSM: $18.9B vs. MDWD: $208.26M
INSM [@Biotechnology] is valued at $18.9B. MDWD’s [@Biotechnology] market capitalization is $208.26M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INSM’s FA Score shows that 1 FA rating(s) are green whileMDWD’s FA Score has 1 green FA rating(s).

  • INSM’s FA Score: 1 green, 4 red.
  • MDWD’s FA Score: 1 green, 4 red.
According to our system of comparison, both INSM and MDWD are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INSM’s TA Score shows that 6 TA indicator(s) are bullish while MDWD’s TA Score has 6 bullish TA indicator(s).

  • INSM’s TA Score: 6 bullish, 4 bearish.
  • MDWD’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, both INSM and MDWD are a good buy in the short-term.

Price Growth

INSM (@Biotechnology) experienced а -3.11% price change this week, while MDWD (@Biotechnology) price change was +0.89% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.22%. For the same industry, the average monthly price growth was +31.37%, and the average quarterly price growth was +12.88%.

Reported Earning Dates

INSM is expected to report earnings on Jul 31, 2025.

MDWD is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+4.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INSM($18.9B) has a higher market cap than MDWD($208M). INSM YTD gains are higher at: 44.105 vs. MDWD (8.202). MDWD has higher annual earnings (EBITDA): -29.43M vs. INSM (-917.87M). INSM has more cash in the bank: 1.2B vs. MDWD (38.3M). MDWD has less debt than INSM: MDWD (6.42M) vs INSM (1.14B). INSM has higher revenues than MDWD: INSM (381M) vs MDWD (19.2M).
INSMMDWDINSM / MDWD
Capitalization18.9B208M9,087%
EBITDA-917.87M-29.43M3,119%
Gain YTD44.1058.202538%
P/E RatioN/AN/A-
Revenue381M19.2M1,984%
Total Cash1.2B38.3M3,131%
Total Debt1.14B6.42M17,793%
FUNDAMENTALS RATINGS
INSM vs MDWD: Fundamental Ratings
INSM
MDWD
OUTLOOK RATING
1..100
5055
VALUATION
overvalued / fair valued / undervalued
1..100
96
Overvalued
68
Overvalued
PROFIT vs RISK RATING
1..100
1185
SMR RATING
1..100
10098
PRICE GROWTH RATING
1..100
3650
P/E GROWTH RATING
1..100
1003
SEASONALITY SCORE
1..100
385

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MDWD's Valuation (68) in the Pharmaceuticals Other industry is in the same range as INSM (96) in the Biotechnology industry. This means that MDWD’s stock grew similarly to INSM’s over the last 12 months.

INSM's Profit vs Risk Rating (11) in the Biotechnology industry is significantly better than the same rating for MDWD (85) in the Pharmaceuticals Other industry. This means that INSM’s stock grew significantly faster than MDWD’s over the last 12 months.

MDWD's SMR Rating (98) in the Pharmaceuticals Other industry is in the same range as INSM (100) in the Biotechnology industry. This means that MDWD’s stock grew similarly to INSM’s over the last 12 months.

INSM's Price Growth Rating (36) in the Biotechnology industry is in the same range as MDWD (50) in the Pharmaceuticals Other industry. This means that INSM’s stock grew similarly to MDWD’s over the last 12 months.

MDWD's P/E Growth Rating (3) in the Pharmaceuticals Other industry is significantly better than the same rating for INSM (100) in the Biotechnology industry. This means that MDWD’s stock grew significantly faster than INSM’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
INSMMDWD
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
88%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
78%
Bullish Trend 3 days ago
90%
Momentum
ODDS (%)
Bullish Trend 5 days ago
77%
Bearish Trend 3 days ago
81%
MACD
ODDS (%)
N/A
Bearish Trend 3 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
73%
Bullish Trend 3 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
73%
Bearish Trend 3 days ago
79%
Advances
ODDS (%)
Bullish Trend 7 days ago
69%
Bullish Trend 14 days ago
77%
Declines
ODDS (%)
Bearish Trend 3 days ago
75%
Bearish Trend 3 days ago
82%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
83%
Bullish Trend 3 days ago
81%
Aroon
ODDS (%)
Bullish Trend 3 days ago
73%
Bullish Trend 3 days ago
76%
View a ticker or compare two or three
Interact to see
Advertisement
INSM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MDWD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SPTN26.510.11
+0.42%
SpartanNash Company
NICE165.09-0.60
-0.36%
NICE Ltd
JVA4.25-0.14
-3.19%
Coffee Holding Co
UEC6.71-0.34
-4.82%
Uranium Energy Corp
BDSX0.25-0.03
-9.54%
Biodesix

INSM and

Correlation & Price change

A.I.dvisor indicates that over the last year, INSM has been closely correlated with THAR. These tickers have moved in lockstep 74% of the time. This A.I.-generated data suggests there is a high statistical probability that if INSM jumps, then THAR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INSM
1D Price
Change %
INSM100%
-2.21%
THAR - INSM
74%
Closely correlated
+2.41%
KRYS - INSM
42%
Loosely correlated
-2.60%
ROIV - INSM
42%
Loosely correlated
-1.81%
CRNX - INSM
41%
Loosely correlated
-1.48%
RNA - INSM
40%
Loosely correlated
-2.68%
More

MDWD and

Correlation & Price change

A.I.dvisor indicates that over the last year, MDWD has been loosely correlated with PHIO. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if MDWD jumps, then PHIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MDWD
1D Price
Change %
MDWD100%
-0.67%
PHIO - MDWD
35%
Loosely correlated
N/A
AKRO - MDWD
33%
Poorly correlated
-0.16%
KANT - MDWD
30%
Poorly correlated
+15.88%
VCEL - MDWD
28%
Poorly correlated
+0.17%
INSM - MDWD
27%
Poorly correlated
-2.21%
More